Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas
Pediatric Blood and Cancer
Volume 60, Issue 5
Antibodies; Monoclonal; Humanized--adverse effects; Antibodies; Monoclona; Humanized--therapeutic use; Brain Neoplasms--drug therapy; Glioma--drug therapy; Neoplasm Recurrence; Local--drug therapy
Hwang, E. I., Jakacki, R. I., Fisher, M. J., Kilburn, L. B., Horn, M., Vezina, G., Rood, B.R., Packer, R. J. (2013). Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatric Blood and Cancer, 60(5), 776-782.